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Abstract
Background: The relationship between colorectal cancer (CRC) risk and physical activity and
dietary habits has been well-established, but less is known about the relationship between these
behaviours and quality of life (QOL) post-diagnosis. Moreover, it is unknown whether this
relationship is consistent across cancer stage or treatment setting. Thus, the purpose of this study
was to assess current diet and physical activity behaviour in CRC survivors receiving systemic
chemotherapy, and to examine potential associations between these behaviours and quality of life.
A secondary purpose was to examine the association between social support, diet, and physical
activity behaviour in this population.
Methods: Using a cross-sectional survey, 67 CRC survivors currently receiving chemotherapy in
Calgary, Alberta completed the survey package. Measures included demographic and medical data,
physical activity levels, diet behaviour, QOL, and social support.
Results: In a largely metastatic sample (63%), approximately half were meeting national dietary
guidelines (58%), less were meeting national physical activity guidelines (26%), and a small number
were meeting both (17%). However, only 12.3% (n = 8) reported completely sedentary behaviour,
and 7 of these 8 participants were receiving metastatic treatment. Neither behaviour was
significantly associated with QOL or perceived social support. Furthermore, there were no
significant QOL differences between those treated with palliative intent or adjuvant therapy.
Important group differences emerged between those meeting and not meeting the guidelines, and
associations between QOL, age, BMI, and provisions of social support.
Conclusion: These findings provide insight into lifestyle behaviours of CRC survivors currently
receiving systemic chemotherapy, and the differences in perceived QOL as affected by severity of
disease and treatment setting. Prospective studies in a larger sample of CRC survivors on
chemotherapy are needed to confirm lifestyle behaviour patterns and identify factors related to
QOL that are unique to this population, especially during metastatic treatment.
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Background
Colorectal cancer (CRC) is the second most prevalent can-
cer in Canada and third in the United States for men and
women combined [1,2]. With increased early detection
and effective treatment, as well as an aging population,
the number of CRC survivors is growing significantly.
Although improvements in treatment regimens have ben-
eficially impacted the prognosis of CRC, several quality of
life (QOL) issues result from potential side effects of such
aggressive treatment [3]. Consequently, shifting part of
our focus in research and program development to
address issues of QOL and survivorship has become
essential [4].
Physical activity and diet are two lifestyle behaviours
shown to significantly impact both QOL and survivorship
in cancer populations [5]. Within the CRC population
specifically, physical activity and diet behaviour have
shown both an independent and combined positive asso-
ciation with QOL [6-10]. Specifically, sufficient levels of
physical activity (i.e., meeting published guidelines) or
consuming at least five servings of fruits and vegetables
per day (i.e., 5-A-Day recommendation) have been associ-
ated with significantly higher measures of self-reported
QOL. Additionally, health behaviour clusters have been
identified (i.e., meeting guidelines for multiple behav-
iours such as diet, physical activity, and not smoking)
which appear to have a cumulative impact on QOL [6,7].
It has therefore been suggested that targeting multiple
behaviours may prove more effective in enhancing QOL
than focusing on individual behaviour change in the can-
cer survivor population [5].
However, not all studies concur with this impression. One
recent study in particular found that no lifestyle variable
was a significant predictor of domain-specific or overall
QOL after CRC [11]. This discrepancy may be due, in part,
to the varying QOL and health behaviour measures used,
as well as differing sample characteristics. However, more
research is warranted to determine whether the relation-
ship between lifestyle and QOL persists across stages of
CRC, treatment type (i.e., surgery, chemotherapy, radia-
tion), or setting (i.e., adjuvant or metastatic). For exam-
ple, physical activity trials during treatment in the general
cancer literature have shown mixed results on impacting
QOL. Findings have ranged from negative trends on QOL
subscales, to positive statistically nonsignificant trends, to
moderately significant beneficial effects (i.e, mental
health, role and emotional functioning) [12-16].
Furthermore, despite the established link between life-
style and CRC, several reports indicate that adherence to
suggested guidelines for either behaviour is low. For
example, recent studies have reported 25 to 54% of CRC
survivors meeting varied published activity guidelines [7-
10,17], and 16 to 47% achieving the 5-A-Day diet recom-
mendations [7,8]. However, it is unknown whether the
variance in adherence to both behaviours is consistent
across all stages of CRC, or treatment setting. A greater
understanding of factors underlying adherence to either
behaviour would provide important insight into whether
current guidelines are appropriate for all CRC survivors
regardless of stage or treatment, and in turn guide future
behavioural interventions in this population. Since these
behaviours are linked to decreased recurrence risk and
increased survival rates in CRC [18-20], as well as
improved QOL [7], promotion of healthy lifestyle
changes in this population is imperative.
The purpose of this study was to assess current physical
activity and diet behaviour in CRC survivors undergoing
chemotherapy, and examine how these behaviours may
be related to QOL. Based on previous research in CRC, we
hypothesized that adherence to either behaviour guide-
line would be low. However, we did predict that meeting
physical activity and diet guidelines would correspond
with higher self-reported QOL scores. A secondary pur-
pose was to examine the association between social sup-
port, diet, and physical activity behaviour in this
population. It has been suggested that social support may
be a key factor in explaining some of the variance in
healthy behaviours [21-23]. It was hypothesized that
those with greater provisions of social support would
report greater adherence to both behaviour guidelines.
Methods
This study was a cross-sectional survey design using a con-
venience sample of CRC patients currently receiving
chemotherapy. Participants included CRC patients of the
gastrointestinal (GI) tumour group at the Tom Baker Can-
cer Centre (Calgary, AB, Canada). Upon ethical approval
from the Conjoint Health Research Ethics Board, Univer-
sity of Calgary, participants were recruited on-site during
clinic visits in which the medical oncologist first obtained
patient permission to be approached by the researcher.
Eligibility criteria included: a) primary diagnosis of colon
or rectal cancer, b) receiving chemotherapy (adjuvant or
metastatic) not concurrent with radiotherapy, c) at least
18 years of age, and d) ability to read and write in English.
By definition, adjuvant therapy is given with curative
intent after the resection of all detectable disease, whereas
metastatic treatment is given with palliative intent when
the disease has spread to other parts of the body and is no
longer modifiable. Of note, patients receiving radiother-
apy were excluded based on the nutritional implications
associated with this treatment regimen. A total of 112
patients were eligible for the study over a 6-month period,
and 108 consented to complete the survey package and
receive one reminder phone call to return the completed
package.BMC Gastroenterology 2009, 9:60 http://www.biomedcentral.com/1471-230X/9/60
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Measures
The survey package was comprised of demographic and
medical questions, physical activity and diet behaviour
assessments, QOL and social support. Medical data was
obtained through patient records to ensure accuracy. Spe-
cific measures included the following.
Physical Activity Behaviour
Physical activity was assessed using Godin's leisure score
index (LSI) of the GLTEQ (Godin Leisure Time Exercise
Questionnaire) [24]. The LSI is a 3-item measure assessing
the frequency and duration of mild, moderate and stren-
uous bouts of physical activity performed during free time
in a typical week. In this study, participants were asked to
recall their physical activity levels over the past month.
The LSI was then computed into MET hours, which
included only moderate and strenuous activity in the
present study to reflect the Canadian guidelines outlined
in the questionnaire: "At least 30 minutes of moderate
activity 4 or more times per week" [25]. Thus, participants
needed to perform at least 10 MET hours per week to meet
the guideline. The LSI has been successfully used with
adult cancer patients and survivors [26,27], and an inde-
pendent evaluation of its reliability and validity compares
favourably to nine other self-report measures of exercise
[28].
Diet Behaviour
Diet was assessed using a 3-day diet record. This dietary
measure is said to be the most accurate for mean macro-
nutrient content and appropriate for use in studies where
subjects may consume a wide variety of foods [29]. Partic-
ipants were instructed to record their daily consumption
over a period of three days, one of which must be a week-
end day. From the diet records, percent of total recom-
mended daily energy and macronutrient intake (i.e., fat,
carbohydrates, and protein) were assessed based on indi-
vidual height, weight, age, and gender. Servings of fruit
and vegetables were also assessed. Participants were then
classified as meeting or not meeting Canadian diet recom-
mendations based on meeting the appropriate range for
each macronutrient, the appropriate energy intake, and
fruit and vegetable consumption. Specifically, participants
had to be within the acceptable daily macronutrient dis-
tribution ranges for adults: carbohydrates = 45–65% of
total energy intake, proteins = 10–35% of total energy
intake, and fats = 20–35% of total energy intake [30].
These ranges reflect recommended daily servings in Can-
ada's Food Guide [31].
Quality of Life
QOL was assessed using the Functional Assessment of
Cancer Therapy – Colorectal module (FACT-C). This tool
contains five subscales including physical, social-family,
emotional, functional, and a CRC specific concerns sub-
scale. It has been shown to be reliable and valid for assess-
ing QOL within the CRC population [32,33].
Social Support
Perceived social support was assessed using the Social Pro-
visions Scale (SPS), which provides both a global social
support score, and six relational provisions: attachment,
social integration, reassurance of worth, reliable alliance,
guidance, and opportunity to nurture [34]. Scores from
this instrument have been shown to be reliable and valid
within both healthy and cancer populations [22,35].
Analysis
The raw data was analysed using SPSS Version 15.0. The 3-
day diet records were first analysed by a registered Dieti-
cian using Diet Analysis Plus software (Thomson,
Wadsworth, Toronto, ON) to provide total daily energy
intake, and macro and micro-nutrient intake for each par-
ticipant. Reports were specific to participants' age, gender,
self-reported height, and weight. Percentage of recom-
mended daily amounts and macronutrient intake was
then added to the SPSS database for statistical analyses.
After data input and cleaning, the normality of the data
was analyzed (i.e., skewness and kurtosis). The data was
within the requirements of normal distribution, thus no
data transformations were necessary. Descriptive statistics
included means, ranges and standard deviations on all
demographics, medical variables, physical activity and
diet behaviour, QOL, and social support. Individual t-
tests and chi-squares were performed as appropriate to
test differences between those meeting and not meeting
the guidelines for both behaviours. Correlations and anal-
yses of variance examined the relationship between
behaviour, social support and QOL.
Results
Of the 112 eligible participants seen in clinic over a six-
month period, 108 (96%) consented to participate in the
study. A total of 67 packages were returned (response rate
= 62%), of which 63 were completed in full (i.e., both the
questionnaire and 3-day diet record were returned). There
were no statistically significant differences in medical data
between those who completed and those who did not
complete the survey. Sociodemographic data was only
available for those who completed and returned the sur-
vey package.
Sample Characteristics
Complete demographics and medical information for the
study sample (n = 67) is presented in Tables 1 and 2. In
summary, the sample was reflective of national statistics
for CRC. Participants' ages ranged from 29 to 84 years (M
= 60.4), 52.2% were male, the majority were Caucasian
(90.8%), married or common law (81.5%), many had a
university or college education (35.9%), and 30.5% hadBMC Gastroenterology 2009, 9:60 http://www.biomedcentral.com/1471-230X/9/60
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an annual income greater or equal to $80,000. The medi-
cal data shows the mean time since diagnosis for the
entire sample was 13.9 months (SD = 14.1). A small
number of participants had an ostomy appliance (n = 15),
and all participants were currently receiving chemother-
apy with a mean time on active treatment of 5.9 months
(SD = 7.7). More than two thirds were being treated for
metastatic disease (62.7%), and the majority were initial
diagnoses receiving Capecitabine in either treatment set-
ting.
Physical Activity and Diet Behaviour
Descriptive statistics for physical activity and diet behav-
iour can be seen in Table 3. For physical activity behav-
iour, participants (n = 65) had an average of 5.5 MET
hours per week (SD = 9.9). With 10 or more MET hours
needed to satisfy the public activity guidelines, only
26.2% (n = 17) of participants were currently meeting the
minimum amount of weekly physical activity. Reviewing
the average weekly duration and frequency of mild, mod-
erate and strenuous activity, participants were performing
mild activity most often (M = 32.2 minutes; M = 3.1
times/week), followed by moderate activity (M = 11.7
minutes; M = 1.1 times/week), and strenuous activity (M
= 5.4 minutes; M = 0.3 times/week). Of interest, only
12.3% (n = 8) reported sedentary behaviour (i.e., zero
minutes of activity for all three intensities), of which 87.5
(n = 7) were being treated with palliative intent.
With regards to dietary behaviour, the majority of partici-
pants (58.5%) were meeting the national guidelines
examined in this study. Looking at each macronutrient,
participants fell within the acceptable range for carbohy-
drate (50.6%; acceptable range = 45–65%), protein
(17.3%; acceptable range = 10–35%) and fat intake
(31.3%; acceptable range = 20–35%). Furthermore,
despite being on active treatment, on average participants
were meeting more than their individual daily energy
requirements (106.3%). Additionally, for comparison to
previous studies assessing fruit and vegetable intake,
85.2% were achieving their recommended daily servings.
Of note, only 17.5% of all participants met both physical
activity and dietary guidelines.
Quality of Life and Social Support
Social support and QOL scores can be viewed in Table 4.
In summary, mean scores for the SPS were high for our
sample and comparable to healthy population means
[34]. Specifically, reliable alliance (assurance that others
can be counted on in times of stress) was reported as the
Table 1: Participant demographics
Characteristic N Percent
Age (M, SD) 60.4, 13.2
Gender
Male 35 52.2
Female 32 47.8
Race (n = 65)
Caucasian 59 90.8
Asian 5 7.7
Black - -
Hispanic - -
Aboriginal/Métis 1 1.5
Other - -
Marital Status (n = 65)
Married/Common law 53 81.5
Divorced/Separated 5 7.7
Widowed 5 7.7
Never Married 2 3.1
Education Level (n = 64)
Some high school 10 15.6
Completed high school 12 18.8
Some university/college 12 18.8
Completed university/college 23 35.9
Some or completed grad school 7 10.9
Annual Income (n = 59)
<20,000 4 6.8
20,000–39,999 14 23.7
40,000–59,999 17 28.8
60,000–79,999 6 10.2
>80,000 18 30.5
Table 2: Participant medical characteristics
Characteristic N Percent
Months since diagnosis (M, SD)1 3 . 9 ,   14.1
Months on treatment (M, SD)5 . 9 ,   7.7
Ostomy Appliance (n = 67) 15 23.4
Adjuvant Therapy 25 37.3
Colon Stage II 3 4.5
Colon Stage III 20 29.9
Rectal Stage III 2 2.9
Initial diagnosis 21 31.3
Recurrence 4 6.0
Capecitabine 12 17.9
Folfiri 1 1.5
Folfox 9 13.4
Fufa 3 4.5
Metastatic Therapy 42 62.7
Colon Stage IV 39 58.2
Rectal Stage IV 3 4.5
Initial diagnosis 26 38.8
Recurrence 16 23.9
Capecitabine 16 23.9
Folfiri 13 19.4
Folfox 10 14.9
Fufa 2 2.9
Tomudex 1 1.5BMC Gastroenterology 2009, 9:60 http://www.biomedcentral.com/1471-230X/9/60
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highest relational provision (M = 14.7, SD = 1.6), with
opportunity for nurturance (providing assistance to oth-
ers) being the lowest (M = 12.1, SD = 2.2). The FACT-C
scores indicated relatively high overall QOL in our sample
(M = 95.6, SD = 15.7). Social/family well-being was the
highest reported QOL domain (M = 22.6, SD = 4.1), and
physical well-being was the poorest domain (M = 16.7, SD
= 6.1).
Behavioural Associations with Quality of Life
Bivariate correlations were performed between each
behaviour and quality of life for the entire sample. The
only significant findings were that the social/family well-
being subscale was negatively correlated with meeting the
physical activity guidelines (r = -0.301, p = 0.016), and the
CRC-specific concerns subscale was negatively correlated
with meeting the dietary guidelines (r = -0.255, p =
0.044). That is, higher scores on either QOL subscale cor-
related to the participants not meeting the corresponding
behaviour guideline. Analyses of variance were used to
Table 3: Physical Activity and Diet Behaviour
Behaviour MS D
Physical Activity (n = 65)
Total activity duration (minutes) 49.2 51.5
Total activity frequency (times/week) 4.4 3.7
Mild activity duration (minutes) 32.2 36.3
Mild activity frequency (times/week) 3.1 2.8
Moderate activity duration (minutes) 11.7 20.4
Moderate activity frequency (times/week) 1.1 2.0
Strenuous activity duration (minutes) 5.4 18.6
Strenuous activity frequency (times/week) 0.3 1.2
MET hours per week* 5.5 9.9
Diet (n = 65) %S D
Average daily intake of recommended calories 106.3 31.1
Average daily calories from carbohydrate 50.6 7.8
Average daily calories from protein 17.3 4.2
Average daily calories from fat 31.3 6.3
Average daily recommended servings of fruits and vegetables 85.2 57.9
Meeting Guidelines (n = 65) N%
Meeting physical activity guidelines 17 26.2
Meeting dietary guidelines 38 58.5
Meeting guidelines for both behaviours 11 17.5
*MET hours include moderate and strenuous activity to reflect the minimum guidelines of activity stated within the questionnaire (At least 30 
minutes of moderate activity 4 or more times per week, or at least 10 MET hours per week). MET hours was calculated by adding the outcome of 
strenuous frequency × strenuous duration × 9, with moderate frequency × moderate duration × 5, and dividing the sum by 60.
Table 4: Social Support and Quality of Life Descriptives
Measure M SD
Social Provisions Scale
Total social support score (0–96; n = 64) 82.0 9.1
Subscale score (0–16)
Attachment 14.2 1.9
Social integration 13.2 2.0
Reassurance of worth 13.8 1.9
Reliable alliance 14.7 1.6
Guidance 14.0 2.3
Opportunity for nurturance 12.1 2.2
FACT-C (quality of life)
Total QOL score (0–136; n = 63) 95.9 15.7
Subscale score
Physical well-being (0–28) 16.7 6.1
Social/family well-being (0–28) 22.6 4.1
Emotional well-being (0–24) 17.5 4.1
Functional well-being (0–28) 18.5 5.1
CRC-specific concerns (0–28) 20.5 4.2BMC Gastroenterology 2009, 9:60 http://www.biomedcentral.com/1471-230X/9/60
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further explore this relationship. Results from these tests
confirm findings from our correlations, as significant
between group differences on QOL measures were only
found for physical activity and social/family well-being
[F(1,62) = 6.20, p = 0.016], and diet and CRC-specific
concerns [F(1,61) = 4.23, p = 0.044].
Given the limited associations between either behaviour
and QOL, we also performed bivariate correlations to
examine potential significant relationships with medical,
demographic, or social support variables (see Table 5).
The data revealed that BMI was negatively correlated with
QOL (p = 0.033), and age (p = 0.001), total social support
(p = 0.017), attachment (p = 0.010), social integration (p
= 0.001), reliable alliance (p = 0.024), and guidance (p =
0.021) were positively associated with QOL. Of note,
there were no significant differences in QOL scores for
either treatment setting (i.e., adjuvant or metastatic).
Group Differences
Individual t-tests were used to determine the significance
between groups (i.e., those meeting or not meeting the
stated guidelines) for continuous variables, and chi-
square tests were used for categorical variables. Non-para-
metric Mann-U Whitney tests were also performed on
ordinal measures and corresponded with t-test results;
thus, t-tests have been reported. No significant differences
were found in demographics, medical information or
social support scores between those meeting and not
meeting the guidelines for either behaviour.
Discussion
The primary objective of this study was to assess current
physical activity and diet behaviour in CRC survivors cur-
rently receiving systemic chemotherapy, and to examine
associations between these behaviours and QOL. Of
importance, the majority (63%) had significant burden of
disease and were being treated with palliative intent. In
light of these sample characteristics, the percentage of par-
ticipants engaging in sufficient levels of activity and fol-
lowing the public dietary guidelines is impressive,
although only 17% were meeting both behaviour guide-
lines.
Specifically, meeting dietary guidelines, broadly defined
as meeting energy needs, appropriate macronutrient
intakes, and fruit and vegetable intake, was better
achieved in this sample than physical activity when
benchmarked against current public health guidelines for
both behaviours. Approximately half of the participants
(58%) were achieving the appropriate range of daily calo-
ries from each macronutrient (i.e., carbohydrate, protein,
and fat). On average, participants were also meeting or
slightly exceeding their daily energy requirements
(106.3%), which is consistent with intakes observed in
breast cancer survivors [36]. Although previous reports
indicate poor adherence to dietary recommendations in
the CRC population, this has been based on assessing fruit
and vegetable intake as part of the American Cancer Soci-
ety's 5-A-Day campaign [7,8]. While direct comparisons
cannot be made due to different diet assessment tools and
sample characteristics, it should be noted that 85% of the
current sample was meeting individually recommended
servings of fruits and vegetables, which is considerably
higher than previous reports. This may speak to the effec-
tiveness of diet-specific health promotion strategies in the
cancer population at large.
The public physical activity guidelines used in the current
study call for at least 30 minutes of moderate activity, four
or more times per week. Few were meeting these guide-
lines (26%), although this is comparable to other Cana-
dian cancer survivors [37]. In comparison, a large number
of our sample reported weekly mild activity (duration: M
= 32.2 minutes; frequency: M = 3.1 times per week), and
few (12%) reported no activity at all. This is positive,
given the known risks of sedentary behaviour for survivors
includes the development of comorbid conditions and
cancer recurrence. Additionally, with the known potential
side-effects from such aggressive treatment (i.e., neuropa-
thy, hand and foot syndrome, diarrhoea, and nausea),
achieving even mild activity (i.e., below the public activity
guidelines) may be a more realistic goal for those with sig-
nificant burden of disease undergoing treatment, and may
still provide some benefits reported in the general cancer
literature [38,39]. For example, preliminary physical
activity and palliation research found that a 50-minute
physical activity intervention twice a week for six weeks
was feasible in a sample of 34 palliative cancer patients, in
which nine were receiving chemotherapy [40]. Specifi-
cally, circuit training with strength, aerobic, and flexibility
components was successful for improving fitness meas-
ures, symptom management (fatigue), and well-being. Of
importance, intensity of exercise activity was not specified
to the participants.
It is not unexpected that activity levels would be below
recommended levels in this population. Peddle at al.
found that only 9% of a large sample of CRC survivors
Table 5: Correlates between QOL and significant demographic, 
medical, and social support variables
Variable N r p
Age 63 0.409 .001
BMI 62 -0.271 .033
Total social support 63 0.299 .017
Attachment 63 0.321 .010
Social integration 63 0.410 .001
Reliable alliance 63 0.285 .024
Guidance 63 0.291 .021BMC Gastroenterology 2009, 9:60 http://www.biomedcentral.com/1471-230X/9/60
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(60% Stage III or IV disease) reported sufficient activity
levels during treatment, which increased to only 25%
post-adjuvant therapy [10]. Similarly, recent American
and Australian studies have reported that only 32–54% of
CRC survivors meet physical activity guidelines (both dur-
ing and post-treatment survivor samples) [7-9,17]. While
these studies used slightly different guidelines for mini-
mum activity levels (i.e., >150 minutes of moderate activ-
ity per week) than the present study, it is apparent that
activity levels are consistently reported as insufficient in
CRC survivors. As there is a consistent call for establishing
specific dose-response relationships (i.e., per different
cancer type, stage, and treatment status) in the physical
activity and cancer literature, future research should deter-
mine if lower levels of activity than the current guidelines
suggest will still provide clinically meaningful health ben-
efits for CRC survivors on chemotherapy, especially those
with metastatic disease. For example, Spence et al. have
reported their protocol for examining the health benefits
of a supervised exercise program for CRC survivors imme-
diately following adjuvant chemotherapy [41]. Such inter-
ventions are valuable for determining pertinent
differences in achievable activity goals at specific stages of
the cancer continuum and treatment settings.
An unexpected finding and contrary to our hypothesis,
was that neither diet nor physical activity behaviour was
significantly related to global QOL. Physical activity was
negatively correlated to the social/family well-being sub-
scale, and diet was negatively correlated to the CRC-spe-
cific concerns subscale (i.e., treatment-related side
effects). Engaging in physical activity may be seen as tak-
ing away from important social/family interaction and
thereby contribute to the observed negative association
between activity and this subscale. The negative correla-
tion between disease-specific concerns and following the
dietary guidelines is not illogical, however, as the majority
of the items on this subscale are directly related to the
digestive process and those experiencing more symptoms
are likely to adjust their diet to counter this.
The lack of associations between diet, physical activity
and QOL may be due to the small sample of those actually
meeting the physical activity guidelines (n = 17), dietary
guidelines (n = 38), or both (n = 11), thereby making it
difficult to detect significant relationships. Another poten-
tial explanation for this may be that 63% of the current
sample was receiving chemotherapy for metastatic dis-
ease. Thus, this poor prognosis may significantly impact
factors associated with QOL. As this was the first study to
examine the association between lifestyle behaviours and
QOL in a largely metastatic sample receiving systemic
chemotherapy, these findings are important and need to
be replicated.
With regards to QOL levels in the current study, both glo-
bal and domain-specific QOL scores were lower than
those reported in two previous CRC studies using the
same measure. Specifically, the current sample reported a
mean global QOL score of 95.9 (out of 136), compared to
the means of 111.5 and 110 in these two previous studies
[9,10]. Interestingly, the physical well-being domain score
was the lowest of the five subscales in the present sample
(M = 16.7; out of 28), but highest in the two other studies
(M = 23.6 and 24). The lower QOL scores in the present
sample likely reflect that the participants were undergoing
adjuvant or metastatic treatment. The other two studies
included CRC survivors both on and off treatment, and
previous studies have reported that global QOL levels
tend to increase over time (i.e., after treatment comple-
tion) in this population [42]. Understanding the specific
domains of QOL most affected in CRC survivors, which
appears to vary according to severity of disease and treat-
ment setting, is valuable for tailoring future interventions
targeting QOL outcomes.
In a further attempt to understand QOL in the current
sample, exploratory analyses examined significant rela-
tionships between QOL and demographic, medical, and
social support variables. It appears in this sample that
BMI, age, and social support provisions have stronger cor-
relations with perceived QOL than do the lifestyle behav-
iours. Specifically, lower BMI, older age, and greater
provisions of attachment, social integration, guidance,
and reliable alliance were significantly associated with
overall QOL. Interestingly, no significant differences on
any QOL scales were found between those treated in the
adjuvant or metastatic setting. Contrary to what one
might expect, this may imply that QOL is no worse when
treated with palliative intent as compared to adjuvant
therapy in this population. This needs to be confirmed in
future studies.
With respect to age, Arndt et al. also found that younger
CRC survivors reported worse QOL in functioning and
symptom scales than older survivors [42]. It has been
hypothesized from breast cancer studies that younger sur-
vivors may have less coping strategies and view their can-
cer as a greater threat to their lives [43-45]. The BMI and
QOL correlation is also consistent with past research,
which noted that those with lower BMIs reported higher
perceived QOL [46]. A larger sample may replicate these
findings, but also suggests that future studies with QOL as
the primary endpoint may need to tailor interventions to
age-specific needs of the participants.
The relationship between QOL and social support provi-
sions found in this study is supportive of the findings in
previous QOL and CRC research. Dunn and colleaguesBMC Gastroenterology 2009, 9:60 http://www.biomedcentral.com/1471-230X/9/60
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found that participants expressed emotional, instrumen-
tal, and spiritual support as most beneficial to their cancer
experience [47], and Sultan et al. found that provision of
emotional and instrumental support corresponded with
improved QOL in survivors [48]. In addition, the recent
work of Steginga et al. found social support to be signifi-
cantly associated with all domains of QOL, and a signifi-
cant independent predictor of social well-being,
functional well-being, and overall QOL [11]. Although
varying measures of social support were used in these
studies, the culmination of these findings suggest that
social support may be more directly related to subjective
well-being for CRC survivors, and a key target for future
QOL research in this population. However, as stated pre-
viously, knowing if this relationship is consistent along
the cancer continuum or varies with stage and treatment
of CRC needs to be investigated.
Although the present study was the first to look at both
physical activity and diet behaviour exclusively in CRC
survivors receiving chemotherapy, and the association
between these behaviours and QOL, there are limitations
to be noted. Primarily, the small and convenience sample
limits the generalizability of the findings and ability to
detect statistically meaningful relationships. Furthermore,
the self-report nature of behaviour and the potential for
social desirability may have influenced reporting for
either behaviour. Using objective measures of behaviour
in a larger sample to replicate these findings is important
for providing the baseline data to effectively design future
lifestyle trials in this population.
Conclusion
In summary, this study found novel and important base-
line information on current dietary and physical activity
behaviour in the CRC population undergoing systemic
chemotherapy. In light of our sample characteristics, espe-
cially the significant burden of disease in the majority of
participants, the number who are engaging in physical
activity is positive, and the high percentage following
healthy food guidelines even more so. Moreover, the
largely metastatic sample presents an understudied and
important area for future research. Having these baseline
measures are essential for future lifestyle research initia-
tives in this population, which are likely to vary with can-
cer stage and the different phases of the cancer experience.
As well, our findings provide insight into the differences
in perceived QOL as affected by treatment setting and
severity of disease, compared with existing literature
reporting QOL post-treatment and into survivorship in
samples with less advanced disease. Evidence-based inter-
ventions are warranted in this population, especially to
determine appropriate dose-response relationships
between activity or diet and meaningful health benefits
for survivors being treated with adjuvant or metastatic
chemotherapy. Furthermore, the role of social support
and other potential variables more highly associated with
QOL should be explored to effectively target QOL out-
comes specific to diagnosis and treatment.
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